Jan 28, 2023 1:04 PM
BACK TO TOP
KSE100
40,450.53
-396.00
(-0.97%)
ALLSHR
26,921.40
-265.00
(-0.97%)
KSE30
15,109.93
-101.67
(-0.67%)
KMI30
68,732.25
-1041.31
(-1.49%)
BKTi
9,403.86
-27.93
(-0.30%)
OGTi
11,452.87
-2.11
(-0.02%)
KMIALLSHR
19,501.73
-214.81
(-1.09%)
PSXDIV20
13,647.34
-80.62
(-0.59%)
UPP9
11,164.00
-71.53
(-0.64%)
NITPGI
9,211.35
-60.60
(-0.65%)
NBPPGI
10,725.43
-27.84
(-0.26%)
MZNPI
8,755.79
-131.78
(-1.48%)
JSMFI
8,752.44
-160.54
(-1.80%)
ACI
6,491.16
-197.24
(-2.95%)
HBLTTI
10,683.38
26-01-2023
18.64
(0.17%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.81.01
-1.12
(-1.36%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Jan 27, 2023 4:35 PM
REG
FUT
ODL
Open
81.50
High
82.45
Low
80.59
Volume
10,800
CIRCUIT BREAKER
75.97 — 88.29
DAY RANGE
80.59 — 82.45
52-WEEK RANGE
80.00 — 144.70
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
82.13
VAR
11.00
HAIRCUT
15.00
P/E Ratio (TTM) **
7.97
1-Year Change *
-39.02%
YTD Change *
-7.70%

No record found

Open
81.50
High
85.00
Low
81.00
Close
81.10
Change
-1.25%
LDCP
82.13
Volume
169
Total Trades
11
CIRCUIT BREAKER
73.92 — 90.34
DAY RANGE
81.00 — 85.00
Ask Price
83.59
Ask Volume
10
Bid Price
81.02
Bid Volume
25
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Ms. Erum Shakir RahimCEO
Chairman
Ms. Mehar-e-daraksha AmeerCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
25,799,034.19
Shares
318,467,278
Free Float
52,130,888
Free Float
16.37%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 28, 2022Transmission of Quarterly Report for the Period Ended September 30, 2022 View   PDF
Oct 25, 2022Financial Results for the Quarter Ended September 30, 2022 View   PDF
Aug 29, 2022Transmission of Quarterly Report for the Period Ended June 30, 2022 View   PDF
Aug 23, 2022Financial Results for the Quarter Ended June 30, 2022 View   PDF
May 6, 2022Transmission of Quarterly Report for the Period Ended March 31, 2022 View   PDF
Apr 26, 2022Financial Results for the Quarter Ended March 31, 2022 View   PDF
Apr 4, 2022Transmission of Annual Report for the Year Ended 2021-12-31 View   PDF
Feb 25, 2022Financial Results for the Year Ended December 31 2021 View   PDF
Oct 29, 2021Transmission of Quarterly Report for the Period Ended September 30, 2021 View   PDF
Oct 25, 2021Financial Results for the Quarter Ended September 30, 2021 View   PDF
DateTitleDocument
Oct 18, 2022Board Meeting View   PDF
Aug 16, 2022Board of Directors Meeting - August 23, 2022 View   PDF
Apr 25, 2022Board Meeting In Progress View   PDF
Apr 25, 2022Certified True Copy of Resolution - Annual General Meeting View   PDF
Apr 18, 2022Board Meeting View   PDF
Apr 4, 2022Notice of Annual General Meeting View   PDF
Feb 18, 2022BOARD OF DIRECTORS MEETING View   PDF
Oct 18, 2021Board of Directors Meeting View   PDF
Aug 20, 2021Board Meeting Reschedule View   PDF
Aug 16, 2021Board of Directors Meeting View   PDF
DateTitleDocument
Nov 24, 2022Notice of Corporate Briefing Session 2022 View   PDF
Sep 28, 2022Appointment of Non-Executive Director View   PDF
Sep 28, 2022Appointment of Non-Executive Director View   PDF
Sep 16, 2022GLAXO | GlaxoSmithKline Pakistan Limited
REVISED
PDF
Sep 16, 2022GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information
REVOKED
PDF
Aug 12, 2022Appointment of Ms. Lai Kuen Goh - Chairperson and Non-Executive Director View   PDF
Aug 10, 2022Resignation of Mr. Dmytro Oliinyk from the Board of GlaxoSmithKline Pakistan Limited View   PDF
Jun 30, 2022Material Information - Resignation of Mark Dawson as Director w.e.f. 30 June 2022 View   PDF
Jun 8, 2022Material Information View   PDF
May 10, 2022Credit of Final Cash Dividend 2021 View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales36,660,77235,090,11236,581,74934,006,840
Profit after Taxation5,354,4093,375,2403,041,1233,257,951
EPS16.8110.609.5510.23
Q3 2022Q2 2022Q1 2022Q3 2021
Sales11,925,6629,542,3778,625,9649,825,226
Profit after Taxation148,664(293,829)925,0411,195,203
EPS0.47(0.92)2.903.75
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)26.5621.4721.0824.74
Net Profit Margin (%)14.619.628.319.58
EPS Growth (%)58.5810.99(6.65)9.29
PEG0.141.65(2.53)1.19

Payouts

DateFinancial ResultsDetailsBook Closure
February 28, 2022 11:32 AM31/12/2021(YR) 70%(F) (D) 19/04/2022 - 25/04/2022
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014

Financial Reports